Skip to main content

Peer Review reports

From: Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema

Original Submission
17 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
3 Mar 2022 Reviewed Reviewer Report
2 Apr 2022 Reviewed Reviewer Report
28 Apr 2022 Author responded Author comments - Hidetaka Noma
Resubmission - Version 4
28 Apr 2022 Submitted Manuscript version 4
30 May 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
31 May 2022 Editorially accepted
4 Jun 2022 Article published 10.1186/s12886-022-02478-9

You can find further information about peer review here.

Back to article page